Noteworthy Cardiac Literature From 2021: Coronary Guideline Change Without New Data,Heart Transplant Donation After Cardiac Death,Covid Effects on Global Cardiac Surgery,and Attempt to Improve Dissection Remodeling
Restricted accessReview articleFirst published online June, 2022
Noteworthy Cardiac Literature From 2021: Coronary Guideline Change Without New Data,Heart Transplant Donation After Cardiac Death,Covid Effects on Global Cardiac Surgery,and Attempt to Improve Dissection Remodeling
Cardiac surgery continues to evolve. The last year has been notable for many reasons. The guidelines for coronary revascularization introduced significant discord. The pandemic continues to affect the care on a global scale. Advances in organ procurement and dissection care move forward with better understanding and better technology.
LawtonJSTamis-HollandJEBangaloreS, et al.2021 ACC/AHA/SCAI guideline for coronary artery revascularization: A report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2022;145:e18-e114. doi:10.1161/CIR.0000000000001038
2.
SabikJF3rdBakaeenFGRuelM, et al.The American association for thoracic surgery and the society of thoracic surgeons reasoning for not endorsing the 2021 ACC/AHA/SCAI coronary revascularization guidelines. Ann Thorac Surg. 2022;113:1065-1068. PMID: 34954249. doi:10.1016/j.athoracsur.2021.12.003
NeumannF-JSousa-UvaMAhlssonA, et al.2018 ESC/EACTS guidelines on myocardial revascularization. European Heart JournalEur Heart J. 2019;40(37):3096. doi:10.1093/eurheartj/ehy394. PMID: 30165437.
5.
ThuijsDJFMKappeteinAPSerruysPW, et al.Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet. 2019;394:1325-1334.
6.
MohrFWMoriceM-CKappeteinAP, et al.Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013;381(9867):629-638. doi:10.1016/S0140-6736(13)60141-5. PMID: 23439102.
7.
StoneGWKappeteinAPSabikJF, et al.Five-year outcomes after PCI or CABG for left main coronary disease. N Engl J Med. 2019;381(19):1820-1830. doi:10.1056/NEJMoa1909406. PMID: 31562798.
8.
MaronDJHochmanJSReynoldsHR, et al.Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. 2020;382:1395-1407. doi:10.1056/NEJMoa1915922. PMC7263833. Epub 2020 Mar 30. PMID: 32227755.
9.
DebSCohenEASinghSKUneDLaupacisAFremesSE. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery. J Am Coll Cardiol. 2012;60(1):28-35. doi:10.1016/j.jacc.2012.03.037. PMID: 22742399.
10.
GoldmanSSethiGKHolmanW, et al.Radial artery grafts vs saphenous vein grafts in coronary artery bypass surgery. JAMA. 2011;305(2):167-174. doi:10.1001/jama.2010.1976. PMID: 21224458.
11.
CollinsPWebbCMChongCFMoatNE. Radial artery versus saphenous vein patency randomized trial. Circulation. 2008;117(22):2859-2864. doi:10.1161/CIRCULATIONAHA.107.736215. Epub 2008 May 27. PMID: 18506009.
12.
BuxtonBFHaywardPARamanJ, et al.Long-term results of the RAPCO trials. Circulation. 2020;142(14):1330-1338. doi:10.1161/CIRCULATIONAHA.119.045427. Epub 2020 Oct 5. PMID: 33017209.
13.
SchwannTAHabibRHWallaceA, et al.Operative outcomes of multiple-arterial versus single-arterial coronary bypass grafting. Ann Thorac Surg. 2018;105(4):1109-1119. doi:10.1016/j.athoracsur.2017.10.058. Epub 2018 Feb 14. PMID: 29453002.
14.
GaudinoMBakaeenFGBenedettoU, et al.Arterial grafts for coronary bypass. Circulation. 2019;140(15):1273-1284. doi:10.1161/CIRCULATIONAHA.119.041096. Epub 2019 Oct 7. PMID: 31934782.
15.
LoopFDLytleBWCosgroveDM, et al.Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314(1):1-6. doi:10.1056/NEJM198601023140101. PMID: 3484393.
16.
BoucekMMMashburnCDunnSM, et al.Pediatric heart transplantation after declaration of cardiocirculatory death. N Engl J Med. 2008;359(7):709-714. doi:10.1056/NEJMoa0800660. PMID: 18703473.
17.
HoffmanJRHMcMasterWGRaliAS, et al.Early US experience with cardiac donation after circulatory death (DCD) using normothermic regional perfusion. J Heart Lung Transplant. 2021;40(11):1408-1418. doi:10.1016/j.healing.2021.06.022. PMID: 34334301.
18.
AlkireBCRaykarNPShrimeMG, et al.Global access to surgical care: A modelling study. Lancet Global Health. 2015;3:e316-e323.
19.
ZillaPYacoubMZühlkeL, et al.Global unmet needs in cardiac surgery. Global Heart. 2018;13:293-303.
20.
COVIDSurg Collaborative. Elective surgery cancellations due to the COVID-19 pandemic: Global predictive modelling to inform surgical recovery plans. Br J Surg. 2020;107:1440-1449.
21.
GaudinoMChikweJHameedIRobinsonNBFremesSERuelM. Response of cardiac surgery units to COVID-19. Circulation. 2020;142:300-302.
22.
NguyenTCThouraniVHNissenAP, et al.The effect of COVID-19 on adult cardiac surgery in the united states in 717 103 patients. Ann Thorac Surg. 2022;113:738-746.
23.
EinsteinAJShawLJHirschfeldC, et al.International impact of COVID-19 on the diagnosis of heart disease’international impact of COVID-19 on the diagnosis of heart disease. J Am Coll Cardiol. 2021;77:173-185.
24.
KitaharaSFujinoMHondaS, et al.COVID-19 pandemic is associated with mechanical complications in patients with ST-elevation myocardial infarction. Open Heart. 2021;8:e001497.
25.
Rich-EdwardsJWDingMRocheleauCM, et al.American frontline healthcare personnel’s access to and use of personal protective equipment early in the COVID-19 pandemic. J Occup Environ Med. 2021;63:913-920.
26.
BatistaCHotezPAmorYB, et al.The silent and dangerous inequity around access to COVID-19 testing: A call to action. EClinicalMedicine. 2022;43:101230.
27.
GeorgeISalnaMKobsaS, et al.The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: Insights and clinical strategies from a center at the epicenter. Ann Thorac Surg. 2020;110:1108-1118.
28.
CaruanaEJPatelAKendallSRathinamS. Impact of coronavirus 2019 (COVID-19) on training and well-being in subspecialty surgery: A national survey of cardiothoracic trainees in the United Kingdom. J Thorac Cardiovasc Surg. 2020;160:980-987.
29.
EngelmanDTLotherSGeorgeI, et al.Adult cardiac surgery and the COVID-19 pandemic: Aggressive infection mitigation strategies are necessary in the operating room and surgical recovery. J Thorac Cardiovasc Surg. 2020;160:447-451.
30.
SandersJAkowuahECooperJ, et al.Cardiac surgery outcome during the COVID-19 pandemic: A retrospective review of the early experience in nine UK centres. J Cardiothorac Surg. 2021;16:43.
31.
ByrnesMEBrownCSDe RooAC, et al.Elective surgical delays due to COVID-19. Med Care. 2021;59:288-294.
World Health Organization, International bank for reconstruction and development/the World bank. 2021. ‘Global monitoring report on financial protection in health 2021’. Licence: CC BY-NC-SA 3.0 IGO.
34.
ShrimeMGDareAJAlkireBCO’NeillKMearaJG. Catastrophic expenditure to pay for surgery worldwide: A modelling study. Lancet Global Health. 2015;3:S38-S44.
35.
LombardiJVCambriaRPNienaberCA, et al.Prospective multicenter clinical trial (STABLE) on the endovascular treatment of complicated type B aortic dissection using a composite device design. J Vasc Surg. 2012;55(3):629-640. doi:10.1016/j.jvs.2011.10.022. PMID: 22169668.
36.
LombardiJVGleasonTGPannetonJM, et al.STABLE II clinical trial on Endovascular treatment of acute, complicated type B aortic dissection with a composite device design. J Vasc Surg. 2020;71(4):1077-1087. doi:10.1016/j.jvs.2019.06.189. PMID 31477479.
37.
BozsoSJNagendranJChuMWA, et al.Midterm outcomes of the dissected aorta repair through stent implantation trial. Ann Thorac Surg. 2021;111(2):463-470. doi:10.1016/j.athoracspur.2020.02.090. PMID: 32673661.
